Omega-3s and cancer
This article was originally published in The Tan Sheet
"Dietary supplementation with omega-3 fatty acids is unlikely to prevent cancer," Catherine MacLean, MD/PhD, RAND Health, et al., conclude in the Jan. 25 Journal of the American Medical Association. The authors analyzed 38 articles in 20 different cohorts identified through a database search. Among the 65 estimates of association between omega-3s and cancer identified across the cohorts, only 10 are statistically significant, the authors state. Significant associations between omega-3 fatty acid consumption and cancer risk were reported for breast, colorectal, lung, prostate and skin cancers. However, there were significant associations for both increased risk and decreased risk and "far more estimates that did not demonstrate any association," MacLean et al. state. Omega-3 consumption "varied a great deal" across the studies, but "basically no effect was found in any of the cohorts," the authors state. "This difference could be regarded as evidence that omega-3 fatty acids have no effect regardless of intake"...
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.